These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 27333149)

  • 1. PTEN expression is associated with the outcome of lung cancer: evidence from a meta-analysis.
    Gu J; Ou W; Huang L; Wu J; Li S; Xu J; Feng J; Liu B; Zhou Y
    Minerva Med; 2016 Oct; 107(5):342-51. PubMed ID: 27333149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma.
    Yanagawa N; Leduc C; Kohler D; Saieg MA; John T; Sykes J; Yoshimoto M; Pintilie M; Squire J; Shepherd FA; Tsao MS
    J Thorac Oncol; 2012 Oct; 7(10):1513-21. PubMed ID: 22982652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN expression is a prognostic marker for patients with non-small cell lung cancer: a systematic review and meta-analysis of the literature.
    Xiao J; Hu CP; He BX; Chen X; Lu XX; Xie MX; Li W; He SY; You SJ; Chen Q
    Oncotarget; 2016 Sep; 7(36):57832-57840. PubMed ID: 27506936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of phosphatase and tensin homolog expression correlates with clinicopathological features of non-small cell lung cancer patients and its impact on survival: A systematic review and meta-analysis.
    Zhao Y; Zheng R; Li J; Lin F; Liu L
    Thorac Cancer; 2017 May; 8(3):203-213. PubMed ID: 28263037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study.
    Personeni N; Rimassa L; Verusio C; Barni S; Rubino L; Bozzarelli S; Villa E; Carnaghi C; Tronconi MC; Gerardi C; Galli F; Floriani I; Destro A; Raschioni C; Labianca R; Santoro A
    Clin Colorectal Cancer; 2015 Sep; 14(3):162-9. PubMed ID: 25861836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN in kidney cancer: A review and meta-analysis.
    Que WC; Qiu HQ; Cheng Y; Liu MB; Wu CY
    Clin Chim Acta; 2018 May; 480():92-98. PubMed ID: 29408173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer.
    Ludovini V; Bianconi F; Pistola L; Chiari R; Minotti V; Colella R; Giuffrida D; Tofanetti FR; Siggillino A; Flacco A; Baldelli E; Iacono D; Mameli MG; Cavaliere A; Crinò L
    J Thorac Oncol; 2011 Apr; 6(4):707-15. PubMed ID: 21258250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Expression of PTEN is Associated with Worse Prognosis in Patients with Cancer.
    Qiu ZX; Zhao S; Li L; Li WM
    Asian Pac J Cancer Prev; 2015; 16(11):4691-8. PubMed ID: 26107225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.
    Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
    Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinoma.
    Kim HR; Cho BC; Shim HS; Lim SM; Kim SK; Chang J; Kim DJ; Kim JH
    Lung Cancer; 2014 Mar; 83(3):374-82. PubMed ID: 24468202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of Phosphatase and Tensin Homolog Expression Predict Favorable Prognosis in Patients with Non-small Cell Lung Cancer.
    Li X; Yang Y; Zhang H; Yue W; Zhang T; Lu B; Li J; Liu Z; Wang Q; Gao Y; Hu A; Zhang H; Shi H; Hu F; Li B
    Cell Biochem Biophys; 2015 Dec; 73(3):631-7. PubMed ID: 27259304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatase and tensin homolog (PTEN) expression on oncologic outcome in renal cell carcinoma: A systematic review and meta-analysis.
    Tang L; Li X; Gao Y; Chen L; Gu L; Chen J; Lyu X; Zhang Y; Zhang X
    PLoS One; 2017; 12(7):e0179437. PubMed ID: 28672019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN and PIK3CA expression is associated with prolonged survival after gefitinib treatment in EGFR-mutated lung cancer patients.
    Endoh H; Yatabe Y; Kosaka T; Kuwano H; Mitsudomi T
    J Thorac Oncol; 2006 Sep; 1(7):629-34. PubMed ID: 17409929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGR1 predicts PTEN and survival in patients with non-small-cell lung cancer.
    Ferraro B; Bepler G; Sharma S; Cantor A; Haura EB
    J Clin Oncol; 2005 Mar; 23(9):1921-6. PubMed ID: 15774784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive role of phosphatase and tensin homolog (PTEN) loss, phosphoinositol-3 (PI3) kinase (PIK3CA) mutation, and PI3K pathway activation in sensitivity to trastuzumab in HER2-positive breast cancer: a meta-analysis.
    Wang Y; Liu Y; Du Y; Yin W; Lu J
    Curr Med Res Opin; 2013 Jun; 29(6):633-42. PubMed ID: 23574264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG hypermethylation contributes to decreased expression of PTEN during acquired resistance to gefitinib in human lung cancer cell lines.
    Maeda M; Murakami Y; Watari K; Kuwano M; Izumi H; Ono M
    Lung Cancer; 2015 Mar; 87(3):265-71. PubMed ID: 25638724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of PTEN expression as a predictor of resistance to anti-EGFR monoclonal therapy in metastatic colorectal cancer: evidence from retrospective studies.
    Wang ZH; Gao QY; Fang JY
    Cancer Chemother Pharmacol; 2012 Jun; 69(6):1647-55. PubMed ID: 22610356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of PTEN at the transcriptional level is an adverse prognostic factor in female lung adenocarcinomas.
    Inamura K; Togashi Y; Nomura K; Ninomiya H; Hiramatsu M; Okui M; Satoh Y; Okumura S; Nakagawa K; Tsuchiya E; Ishikawa Y
    Lung Cancer; 2007 Aug; 57(2):201-6. PubMed ID: 17452061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of tumor suppressor PTEN in colorectal carcinoma.
    Hsu CP; Kao TY; Chang WL; Nieh S; Wang HL; Chung YC
    Eur J Surg Oncol; 2011 Feb; 37(2):140-7. PubMed ID: 21194879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR inhibitors radiosensitize PTEN-deficient non-small-cell lung cancer cells harboring an EGFR activating mutation by inducing autophagy.
    Kim EJ; Jeong JH; Bae S; Kang S; Kim CH; Lim YB
    J Cell Biochem; 2013 Jun; 114(6):1248-56. PubMed ID: 23592446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.